Cartilage protection by nitric oxide synthase inhibitors after intraarticular injection of interleukin-1β in rats

Arthritis and Rheumatism

Volumn 42, Issue 10, 1999, Pages 2094-2102

  Presle, Nathalie ^a   Cipolletta, Christine ^a   Jouzeau, Jean Yves ^a   Abid, Amr ^a   Netter, Patrick ^a   Terlain, Bernard ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; N(G) METHYLARGININE; N5 (1 IMINOETHYL)ORNITHINE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; RECOMBINANT INTERLEUKIN 1BETA; THIOUREA DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARTILAGE DEGENERATION; CONTROLLED STUDY; DRUG EFFICACY; MALE; NONHUMAN; OSMOTIC MINIPUMP; PATELLA; PRIORITY JOURNAL; PROTECTION; PROTEOGLYCAN SYNTHESIS; RAT; SUPERNATANT; SYNOVIAL FLUID; SYNOVIUM;

ANIMALS; CARTILAGE, ARTICULAR; DRUG ANTAGONISM; ENZYME INHIBITORS; HUMANS; INTERLEUKIN-1; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; ORNITHINE; RATS; RATS, WISTAR;

EID: 0033509828     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199910)42:10<2094::AID-ANR9>3.0.CO;2-Y     Document Type: Article

References (44)

1. Arend WP, Dayer J-M. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 1990;33:305-15.
2. Van de Loo FAJ, Joosten LAB, van Lent PLEM, Arntz OJ, van den Berg WB. Role of interleukin-1, tumor necrosis factor α, and interleukin-6 in cartilage proteoglycan metabolism and destruction: effect of in situ blocking in murine antigen-and zymosan-induced arthritis. Arthritis Rheum 1995;38:164-72.
3. Van de Loo FAJ, Arntz OJ, Otterness IG, van den Berg WB. Protection against cartilage proteoglycan synthesis inhibition by antiinterleukin 1 antibodies in experimental arthritis. J Rheumatol 1992;19:348-56.
4. Caron JP, Fernandes JC, Martel-Pelletier J, Tardif G, Mineau F, Geng C, et al. Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis: suppression of collagenase-1 expression. Arthritis Rheum 1996;39: 1535-44.
5. Bakker AC, Joosten LAB, Arntz OJ, Helsen MMA, Bendele AM, van de Loo FAJ, et al. Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin-1 receptor antagonist protein in the knee. Arthritis Rheum 1997;40:893-900.
6. Pelletier J-P, Caron JP, Evans C, Robbins PD, Georgescu HI, Jovanovic D, et al. In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy. Arthritis Rheum 1997;40:1012-9.
7. Farrell AJ, Blake DR, Palmer RMJ, Moncada S. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 1992;51:1219-22.
8. Grabowski PS, England AJ, Dykhuizen R, Copland M, Benjamin N, Reid DM, et al. Elevated nitric oxide production in rheumatoid arthritis: detection using the fasting urinary nitrate:creatinine ratio. Arthritis Rheum 1996;39:643-7.
9. Palmer RMJ, Hickery MS, Charles IG, Moncada S, Bayliss MT. Induction of nitric oxide synthase in human chondrocytes. Biochem Biophys Res Commun 1993;193:398-405.
10. Bird JLE, Wells T, Platt D, Bayliss MT. IL-1 induces the degradation of equine articular cartilage by a mechanism that is not mediated by nitric oxide. Biochem Biophys Res Commun 1997; 238:81-5.
11. Hayashi T, Abe E, Yamate T, Taguchi Y, Jasin HE. Nitric oxide production by superficial and deep articular chondrocytes. Arthritis Rheum 1997;40:261-9.
12. Cipolletta C, Jouzeau JY, Gegout-Pottie P, Presle N, Bordji K, Netter P, et al. Modulation of IL-1-induced cartilage injury by NO synthase inhibitors: a comparative study with rat chondrocytes and cartilage entities. Br J Pharmacol 1998;124:1719-27.
13. Blanco FJ, Ochs RL, Schwarz H, Lotz M. Chondrocyte apoptosis induced by nitric oxide. Am J Pathol 1995;146:75-85.
14. Cao M, Westerhausen-Larson A, Niyibizi C, Kavalkovich K, Georgescu HI, Rizzo CF, et al. Nitric oxide inhibits the synthesis of type-II collagen without altering Col2A1 mRNA abundance: prolyl hydroxylase as a possible target. Biochem J 1997;324:305-10.
15. Hanglow AC, Rowan K, Lusch L, Coffey JW. Degradation of bovine cartilage proteoglycan in vitro is enhanced by inhibition of nitric oxide synthase. Inflamm Res 1995;44:S151-2.
16. Murrell GAC, Jang D, Williams RJ. Nitric oxide activates metalloprotease enzymes in articular cartilage. Biochem Biophys Res Commun 1995;206:15-21.
17. Stefanovic-Racic M, Morales TI, Taskiran D, McIntyre LA, Evans CH. The role of nitric oxide in proteoglycan turnover by bovine articular cartilage organ cultures. J Immunol 1996;156:1213-20.
18. Taskiran D, Stefanovic-Racic M, Georgescu H, Evans CH. Nitric oxide mediates suppression of cartilage proteoglycan synthesis by interleukin-1. Biochem Biophys Res Commun 1994;200:142-8.
19. Järvinen TAH, Moilanen T, Järvinen TLN, Moilanen E. Nitric oxide mediates interleukin-1 induced inhibition of glycosaminoglycan synthesis in rat articular cartilage. Mediators Inflamm 1995;4: 107-11.
20. Häuselmann HJ, Oppliger L, Michel BA, Stefanovic-Racic M, Evans CH. Nitric oxide and proteoglycan biosynthesis by human articular chondrocytes in alginate cultures. FEBS Lett 1994;352: 361-4.
21. Jouzeau JY, Cipolletta C, Presle N, Netter P, Terlain B. Modulation of IL-1 effect on cartilage by NO synthase inhibitors: pharmacological study in rat. Osteoarthritis Cartilage 1999;7:382-5.
22. Folliard F, Terlain B. A novel method for the sampling of synovial fluid in mice: assay of a synovial lysosomal enzyme in zymosan-induced arthritis. Agents Actions 1988;25:139-45.
23. Nunokawa Y, Ishida N, Tanaka S. Cloning of inducible nitric oxide synthase in rat vascular smooth muscle cells. Biochem Biophys Res Commun 1993;191:89-94.
24. Tso JY, Sun XH, Kao TH, Reece KS, Wu R. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res 1985;13:2485-502.
25. Stadler J, Stefanovic-Racic M, Billiar TR, Curran RD, McIntyre LA, Georgescu HI, et al. Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J Immunol 1991;147:3915-20.
26. Misko TP, Schilling RJ, Salvemini D, Moore WM, Currie MG. A fluorometric assay for the measurement of nitrite in biological samples. Anal Biochem 1993;214:11-6.
27. Van Osch GJVM, van der Kraan PM, van den Berg WB. Site specific inhibition of cartilage proteoglycan synthesis in the murine knee joint: differences between 3 metabolic stimuli. J Rheumatol 1994;21:1107-12.
28. Ueki Y, Miyake S, Tominaga Y, Eguchi K. Increased nitric oxide levels in patients with rheumatoid arthritis. J Rheumatol 1996;23: 230-6.
29. Henrotin YE, Zheng SX, Pulchery Deby G, Labasse AH, Crielaard JMR, Reginster JYL. Nitric oxide downregulates interleukin 1β (IL-1β) stimulated IL-6, IL-8, and prostaglandin E2 production by human chondrocytes. J Rheumatol 1998;25:1595-601.
30. Van Beuningen HM, Arntz OJ, van den Berg WB. In vivo effects of interleukin-1 on articular cartilage: prolongation of proteoglycan metabolic disturbances in old mice. Arthritis Rheum 1991;34: 606-15.
31. Murrell GAC, Phil D, Dolan MM, Jang D, Szabo C, Warren RF, et al. Nitric oxide: an important articular free radical. J Bone Joint Surg Am 1996;78:265-74.
32. Stefanovic-Racic M, Stadler J, Georgescu HI, Evans CH. Nitric oxide synthesis and its regulation by rabbit synoviocytes. J Rheumatol 1994;21:1892-8.
33. Grabowski PS, Macpherson H, Ralston SH. Nitric oxide production in cells derived from the human joint. Br J Rheumatol 1996;35:207-12.
34. McCartney-Francis N, Allen JB, Mizel DE, Albina JE, Xie Q, Nathan CF, et al. Suppression of arthritis by an inhibitor of nitric oxyde synthase. J Exp Med 1993;178:749-54.
35. Cannon GW, Openshaw SJ, Hibbs JB Jr, Hoidal JR, Huecksteadt TP, Griffiths MM. Nitric oxide production during adjuvant-induced and collagen-induced arthritis. Arthritis Rheum 1996;39: 1677-84.
36. Santos LL, Morand EF, Yang Y, Hutchinson P, Holdsworth SR. Suppression of adjuvant arthritis and synovial macrophage inducible nitric oxide by N-iminoethyl-L-ornithine, a nitric oxide synthase inhibitor. Inflammation 1997;21:299-311.
37. Van de Loo FAJ, Arntz OJ, van Enckevort FHJ, van Lent PLEM, van den Berg WB. Reduced cartilage proteoglycan loss during zymosan-induced gonarthritis in NOS2-deficient mice and in anti-interleukin-1-treated wild-type mice with unabated joint inflammation. Arthritis Rheum 1998;41:634-6.
38. Pelletier J-P, Jovanovic D, Fernandes JC, Manning P, Connor JR, Currie MG, et al. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase. Arthritis Rheum 1998;41:1275-86.
39. Stefanovic-Racic M, Meyers K, Meschter C, Coffrey JW, Hoffman RA, Evans CH. N-monomethyl arginine, an inhibitor of nitric oxide synthase, suppresses the development of adjuvant arthritis in rats. Arthritis Rheum 1994;37:1062-9.
40. Stefanovic-Racic M, Meyers K, Meschter C, Coffey JW, Hoffman RA, Evans CH. Comparison of the nitric oxide synthase inhibitors methylarginine and aminoguanidine as prophylactic and therapeutic agents in rat adjuvant arthritis. J Rheumatol 1995;22:1922-8.
41. Jang D, Szabo C, Murrell GAC. S-substituted isothioureas are potent inhibitors of nitric oxide biosynthesis in cartilage. Eur J Pharmacol 1996;312:341-7.
42. Schmidt K, Klatt P, Mayer B. Uptake of nitric oxide synthase inhibitors by macrophage RAW 264.7 cells. Biochem J 1994;301: 313-6.
43. Forray MI, Angelo S, Boyd CAR, Devés R. Transport of nitric oxide synthase inhibitors through cationic amino acid carriers in human erythrocytes. Biochem Pharmacol 1995;50:1963-8.
44. Sakurai H, Kohsaka H, Liu MF, Higashiyama H, Hirata Y, Kanno K, et al. Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J Clin Invest 1995;96:2357-63.